Ancient plant remedies tested in modern arthritis drug trial
NCT ID NCT07429565
Summary
This first-in-human study tested the safety of a new oral drug called APPA-1, which combines two plant-based compounds traditionally used for inflammation. It involved 40 healthy volunteers and people with osteoarthritis to see how the body processes the drug and if it is well-tolerated. The main goal was to find a safe dose and check for side effects before testing if it can relieve pain.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Liverpool University Hospitals NHS Foundation Trust
Liverpool, Merseyside, L7 8XP, United Kingdom
-
University of Liverpool
Liverpool, L69 7ZB, United Kingdom
Conditions
Explore the condition pages connected to this study.